/Lilly(Eli)%20%26%20Co%20logo%20on%20building-by%20Michael%20Vi%20via%20Shutterstock.jpg)
Eli Lilly and Company (LLY), headquartered in Indiana, is a major pharmaceutical firm with a diverse product lineup and a robust pipeline. Its key pharmaceutical categories include neuroscience, diabetes, oncology, and immunology, and the company commands an impressive market cap of $814.9 billion. The leading drug manufacturer plans to release its Q2 earnings for fiscal 2024 on Thursday, Aug. 8.
Ahead of the event, analysts expect Eli Lilly to report a profit of $2.66 per share, up 26.1% from $2.11 per share in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of the last four quarters.